| 25-NBD | 25-[N-[(7-nitro-2-1,3-benzoxadiazol-4-yl)metil]amino]-27-norcolesterol |
| amβCD | mono-(6-amino-6-deoxy)-β-cyclodextrin |
| BT-474 | cells of breast carcinoma |
| CD | cyclodextrin |
| cmβCD | carboxymethyl-β-cyclodextrin |
| CPT | camptothecin |
| DMSO | dimethyl sulfoxide |
| ϕ | fluorescence quantum yield |
| H-460 | cells of lung carcinoma |
| HCT-116 | cells of colorectal carcinoma |
| HPβCD | hydroxypropyl-βCD |
| HS-5 | stroma cells |
| HSA | human serum albumin |
| IC50 | half maximal inhibitory concentration |
| K | association constants |
| MBE | minimal binding energy (MBE) |
| MD | molecular dynamics |
| MM | molecular mechanics |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| MWCO | molecular weight cut-off |
| PBC | periodic boundary conditions |
| PBS | phosphate-buffered saline solution |
| PDI | polydispersity index |
| r | fluorescence anisotropy |
| UV-Vis | using ultraviolet-visible |
| τ | fluorescence lifetime |
| τ1/2 | half-life for a first-order process |